andrew huberman semaglutide The trillion-dollar peptide. Appearing on @tbpn, said retatrutide could be the peptide that “changes everything.” Now in Phase III clinical trials, it's shown up to 30% body weight loss in semaglutide andrew huberman New Lab

For readers focused on broader GLP-1 education, what GLP-1 support means for weight loss is a useful companion read

Why the abdomen absorbs faster The abdomen leads in absorption speed for a straightforward physiological reason

At Week 26, the primary HbA1c endpoint was missing for 4.6% and 3.7% of patients randomized to semaglutide tablets 14 mg and empagliflozin 25 mg, respectively

Jan 29, 2026 You have been researching AOD-9604 for weeks

What I actually see in our clinics The super responders The most striking thing I see on both medications is not the average its the super responders

Oral semaglutide has previously been shown to reduce cardiovascular events in people with type 2 diabetes and pre-existing cardiovascular disease, chronic kidney disease or both in the SOUL trial (McGuire et al, 2025)